Previous Chapter Chapter 19: US Markets for Plaque Modification and Thrombus Management Next Chapter

  • Citations
  • Add to My List
  • Text Size

US Markets for Plaque Modification and Thrombus Management
US markets for plaque modification and thrombus management
Millennium Research Group, A Decision Resources, Inc. Company

The US market for plaque modification and thrombus management was valued in excess of $300 million in 2005. This market, which includes devices used in the coronary, peripheral, and arteriovenous indications, is composed of atherectomy, thrombectomy, chronic total occlusion (CTO), and vascular brachytherapy (VB) devices. Overall, atherectomy device revenues contributed the largest share in the plaque modification and thrombus management market; furthermore, atherectomy devices are forecasted to remain the leading segment through 2010. The plaque modification and thrombus management market will experience noticeable growth in revenue and procedure volumes over the forecast period, driven by increasing physician awareness, further uptake of interventional procedures ...

Looks like you do not have access to this content.

Login

Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website